United States · FDA National Drug Code directory
Sucralfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0904-7470_886b2313-1f47-42e6-b0c9-e19e70b59492
- Product NDC
- 0904-7470
- Form
- SUSPENSION
- Composition / generic term
- SUCRALFATE Oral Suspension
- Labeler
- Major Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240626
- Source listing expiry
- 20271231
Source-listed ingredients
- SUCRALFATE — 1 g/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CUP, UNIT-DOSE in 1 CASE (0904-7470-01) / 10 mL in 1 CUP, UNIT-DOSE (0904-7470-66) · 0904-7470-01
- 40 CUP, UNIT-DOSE in 1 CASE (0904-7470-18) / 10 mL in 1 CUP, UNIT-DOSE (0904-7470-66) · 0904-7470-18
- 20 CUP, UNIT-DOSE in 1 CASE (0904-7470-56) / 10 mL in 1 CUP, UNIT-DOSE (0904-7470-66) · 0904-7470-56
- 10 mL in 1 CUP, UNIT-DOSE (0904-7470-66) · 0904-7470-66
- 100 CUP, UNIT-DOSE in 1 CASE (0904-7470-72) / 10 mL in 1 CUP, UNIT-DOSE (0904-7470-66) · 0904-7470-72
- 50 CUP, UNIT-DOSE in 1 CASE (0904-7470-95) / 10 mL in 1 CUP, UNIT-DOSE (0904-7470-66) · 0904-7470-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →